Abstract
Vibrio parahaemolyticus isolates are generally very sensitive to chloramphenicol. However, it is usually necessary to transfer a plasmid carrying a chloramphenicol resistance gene into V. parahaemolyticus to investigate the function of a specific gene, and the effects of chloramphenicol on bacterial physiology have not been investigated. In this work, the effects of sublethal dose of chloramphenicol on V. parahaemolyticus were investigated by combined utilization of various phenotypic assays and RNA sequencing (RNA-seq). The results showed that the growth rate, biofilm formation capacity, c-di-GMP synthesis, motility, cytotoxicity and adherence activity of V. parahaemolyticus were remarkably downregulated by the sublethal dose of chloramphenicol. The RNA-seq data revealed that 650 genes were significantly differentially expressed in response to chloramphenicol stress, including antibiotic resistance genes, major virulence genes, biofilm-associated genes and putative regulatory genes. This work helps us to understand how chloramphenicol affects the physiology of V. parahaemolyticus.
Introduction
Vibrio parahaemolyticus is a leading cause of seafood-borne gastroenteritis worldwide. To study its pathogenesis, researchers frequently perform genetic knockouts or complementation using plasmids that carry chloramphenicol resistance genes. However, a critical question remains: Does the presence of chloramphenicol itself—even at doses that do not kill the bacteria—skew the results of these experiments? This study investigates how sublethal concentrations of chloramphenicol affect the baseline physiology, behavior, and global gene expression of V. parahaemolyticus to ensure experimental observations are not artifacts of the selection antibiotic.
Methods
The researchers employed a multi-pronged approach combining classical microbiology with transcriptomics:
- Phenotypic Assays: Measurement of growth rates, biofilm formation (via crystal violet staining), and motility (swimming and swarming).
- Virulence Testing: Adhesion and cytotoxicity assays using human HeLa cell lines.
- Molecular Quantification: ELISA quantification of intracellular c-di-GMP, a signaling molecule controlling the transition between mobile and biofilm states.
- Transcriptomics: RNA sequencing (RNA-seq) to map global changes in gene expression under 0.2 μg/mL chloramphenicol stress, validated by qPCR.
Results
Impact on Growth and Phenotype
Exposure to sublethal doses of chloramphenicol resulted in a significant, dose-dependent reduction in growth rate. Beyond growth inhibition, the antibiotic significantly impaired biofilm formation and both swimming and swarming motility at all tested sublethal concentrations.
The c-di-GMP Connection and Virulence Suppression
A key finding was the drastic reduction in intracellular c-di-GMP levels. As a master switch for bacterial lifestyles, this reduction explains the simultaneous downregulation of biofilm and motility pathways. Furthermore, major virulence systems, including Type III Secretion Systems (T3SS1 and T3SS2) and Type VI Secretion Systems (T6SS2), were significantly suppressed. At 0.4 μg/mL, bacterial adhesion to HeLa cells dropped to just 20% of control levels.
Transcriptomic Response
RNA-seq revealed 650 differentially expressed genes (DEGs), with 354 downregulated and 296 upregulated. While virulence and motility genes were suppressed, genes related to antibiotic efflux (like the RND-type pump VmeYZ) and certain transcriptional regulators were upregulated, suggesting a shift from "attack mode" to "survival mode."
Discussion
These results serve as a critical warning for researchers: using chloramphenicol as a selection marker can fundamentally alter the phenotype of V. parahaemolyticus, potentially masking or exaggerating the effects of the genes being studied. Future work will focus on characterizing the specific functions of the identified regulators and exploring the potential for repurposing chloramphenicol-like compounds as anti-virulence agents in food safety or clinical settings.
Summary updated